[DOI] [PubMed] [Google Scholar] 151.Johnson J.J., Nihal M., Siddiqui I.A., Scarlett C.O., Bailey H.H., Mukhtar H., Ahmad N
Di y l mt s trng hp cn cn trng v cn nhc k lng trc khi s dng L-glutathione: s dng L-glutathione an ton v hiu qu, bn cn ch nhng iu sau: Mc d L-glutathione c nhiu li ch i vi c th nh c tnh chng oxy ha mnh m, tuy nhin nu s dng khng ng cch c th gy nn mt s tc dng ph nh: mt s t i tng bo co cc tc dng ph nh sau y trong qu trnh nghin cu glutathione ko di 4 tun vi liu 1g/ngy: Trong mt nghin cu chuyn bit hn lin quan n bnh nhn x nang vi liu L-glutathione cao hn nhiu ghi nhn trng hp b cng cng, tiu chy v cc triu chng ging nh st
PK framing for BPC-157 research Pharmacokinetics (PK) characterises what the body does to the drug absorption, distribution, metabolism, excretion (ADME)
Leon Klempner and Amy Epstein
The anti-amyloid monoclonal antibody lecanemab: 16 cautionary notes